Genetic ablation of ketohexokinase C isoform impairs pancreatic cancer development
OPEN ACCESS
Author / Producer
Date
2023-08-18
Publication Type
Journal Article
ETH Bibliography
yes
Citations
Altmetric
OPEN ACCESS
Data
Rights / License
Abstract
Although dietary fructose is associated with an elevated risk for pancreatic cancer, the underlying mechanisms remain elusive. Here, we report that ketohexokinase (KHK), the rate-limiting enzyme of fructose metabolism, is a driver of PDAC development. We demonstrate that fructose triggers KHK and induces fructolytic gene expression in mouse and human PDAC. Genetic inactivation of KhkC enhances the survival of KPC-driven PDAC even in the absence of high fructose diet. Furthermore, it decreases the viability, migratory capability, and growth of KPC cells in a cell autonomous manner. Mechanistically, we demonstrate that genetic ablation of KHKC strongly impairs the activation of KRAS-MAPK pathway and of rpS6, a downstream target of mTORC signaling. Moreover, overexpression of KHKC in KPC cells enhances the downstream KRAS pathway and cell viability. Our data provide new insights into the role of KHK in PDAC progression and imply that inhibiting KHK could have profound implications for pancreatic cancer therapy.
Permanent link
Publication status
published
External links
Editor
Book title
Journal / series
Volume
26 (8)
Pages / Article No.
107368
Publisher
Elsevier
Event
Edition / version
Methods
Software
Geographic location
Date collected
Date created
Subject
Natural sciences; Biological sciences; Biochemistry; Systems biology; Cancer systems biology
Organisational unit
09703 - Alimonti, Andrea / Alimonti, Andrea
03739 - Stoffel, Markus / Stoffel, Markus
Notes
Funding
176317 - Roles of ketohexokinase signaling and fructose metabolism in pancreatic tumor growth (SNF)